Showing results (161-170 of 219) with videos related to
Sort By:
Pageof 22
Frontiers in Immunology|October 18, 2021
Apoptotic Cells for Therapeutic Use in Cytokine Storm Associated With Sepsis- A Phase Ib Clinical TrialPeter Vernon van Heerden, Avraham Abutbul, Sigal Sviri, et al.Digestive Diseases and Sciences|September 5, 2009
Evaluation of the 13C-octanoate breath test as a surrogate marker of liver damage in animal modelsTamar Shalev, Hussein Aeed, Vladimir Sorin, et al.Immunobiology|November 12, 2016
A plant cell-expressed recombinant anti-TNF fusion protein is biologically active in the gut and alleviates immune-mediated hepatitis and colitisYaron Ilan, Svetlana Gingis-Velitski, Ami Ben Ya'aco, et al.IBRO Neuroscience Reports|March 19, 2026
A feasibility open-label clinical trial utilizing second-generation artificial intelligence based on the constrained-disorder principle in patients with Parkinson's diseaseHillel Lehmann, Henny Azmanov, Yoav Hershkovitz, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|August 9, 2003
Late cytomegalovirus disease following liver transplantationOren Shibolet, Yaron Ilan, Yosef Kalish, et al.World Journal of Gastroenterology|May 27, 2005
Oral immune regulation using colitis extracted proteins for treatment of Crohn's disease: results of a phase I clinical trialEran Israeli, Eran Goldin, Oren Shibolet, et al.Clinical Immunology (Orlando, Fla.)|April 20, 2004
The role of intrahepatic CD8+ T cell trapping and NK1.1+ cells in liver-mediated immune regulationOren Shibolet, Ruslana Alper, Lydia Zolotarov, et al.Journal of Gastroenterology and Hepatology|January 6, 2009
Utility of a 13C-methacetin breath test in evaluating hepatic injury in ratsHaim Shirin, Hussein Aeed, Tamar Shalev, et al.Microbes and Infection|July 10, 2003
Early expression of interferon gamma following oral antigen administration is associated with peripheral tolerance inductionOlga Kolker, Athalia Klein, Roslana Alper, et al.World Journal of Gastroenterology|September 20, 2007
Antioxidant therapy for chronic hepatitis C after failure of interferon: results of phase II randomized, double-blind placebo controlled clinical trialEzra Gabbay, Ehud Zigmond, Orit Pappo, et al.Pageof 22